The goal of this trial is to learn how the Nerivio® device works to treat Amplified Musculoskeletal Pain Syndrome (AMPS) in children ages 8-18. Nerivio® is a wearable device that activates specific nerves in the upper arm. This causes a response from the brain that has been helpful for people who experience migrane headaches. The main questions this study aims to answer are:
* How well does the Nerivio® device help in reducing pain in children with AMPS?
* Does the use of the Nerivio® device help improve quality of life in children with AMPS?
* How satisfied are children and their families with the use of the Nerivio® device for treatment of AMPS?
Researchers will compare the use of the Nerivio® device with usual treatment for AMPS (including pain medications, physical therapy, and other interventions) to see how well the Nerivio® device helps control pain.
Participants will be in one of two groups, decided by:
* Those who are in the "control" group will use their usual practices to control pain.
* Those who are in the "intervention" group will use the Nerivio® device once every other day.
All participants in the "control group" will:
* Complete surveys and answer questions about their pain and how it affects their daily life
* Use their existing methods for pain control.
All participants in the "intervention" group will:
* Complete surveys and answer questions about their pain and how it affects their daily life
* Learn how to work the Nerivio® device and smartphone app.
* Use the Nerivio® device every other day (every 48 hours).